Advances in the relationship between restless leg syndrome and intestinal diseases

doi:10.3877/cma.j.issn.2095-123X.2018.01.010

Abstract

Abstract:

Restless leg syndrome (RLS) is a common clinical disease. Because of its clinical variability, misdiagnosis and mistreatment, it endangers the life and health of patients and seriously affects the quality of life. The pathogenesis of RLS is still unclear. Intestinal diseases such as Celiac disease, irritable bowel syndrome and Crohn’s disease are all associated with RLS. This article reviews the relationship between restless leg syndrome and some intestinal diseases.

Key words: Restless leg syndrome, Intestinal diseases, Celiac disease, Irritable bowel syndrome, Crohn’s disease

Fan Li, Wei Shang. Advances in the relationship between restless leg syndrome and intestinal diseases[J]. Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition), 2018, 08(01): 41-44.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhnkjbykfzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-123X.2018.01.010

https://zhnkjbykfzz.cma-cmc.com.cn/EN/Y2018/V08/I01/41

References 41

[1]	Connor JR, Ponnuru P, Lee BY, et al. Postmortem and imaging based analyses reveal cns decreased myelination in restless legs syndrome[J]. Sleep Med, 2011, 12(6):614-619.
[2]	Celle S, Roche F, Peyron R, et al. Lack of specific gray matter alterations in restlesslegs syndrome in elderly subjects[J]. J Neurol, 2010, 257(3):344-348.
[3]	Belke M, Heverhagen JT, Keil B, et al. DTI and VBM reveal white matter changes without associated gray matter changes in patients with idiopathic restless legs syndrome[J]. Brain Behav, 2015, 5(9):e00327.
[4]	Allen RP, Picchietti DL, Auerbach M, et al. Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report[J]. Sleep Med, 2018, 41, 27-44.
[5]	Krieger J, Schroeder C. Iron, brain and restless legs syndrome[J]. Sleep Med Rev, 2001, 5(4):277-286.
[6]	Khlevner J, Park Y, Margolis KG. Brain-Gut Axis: Clinical Implications[J]. Gastroenterol Clin North Am, 2018, 47(4):727-739.
[7]	Costa M, Brookes SJ, Hennig GW. Anatomy and physiology of the enteric ner-vous system[J]. Gut, 2000, 47(Suppl 4):iv15-9, discussion iv26.
[8]	Gershon MD. Developmental determinants of the independence and complexity of the enteric nervous system[J]. Trends Neurosci, 2010, 33(10):446-456.
[9]	Smith PA. The tantalizing links between gut microbes and the brain[J]. Nature, 2015, 526(7573):312-314.
[10]	Rewers M. Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease?[J]. Gastroenterology, 2005, 128(4 Suppl.1):S47-51.
[11]	Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study[J]. Arch Intern Med, 2003, 163(3):286-292.
[12]	Fasano A. Celiac disease-how to handle a clinical chameleon[J]. N Engl J Med, 2003, 348(25):2568-2570.
[13]	Chand N, Mihas AA. Celiac disease: current concepts in diagnosis and treatment[J]. J Clin Gastroenterol, 2006, 40(1):3-14.
[14]	Green PH, Cellier C. Celiac disease[J]. N Engl J Med, 2007, 357(17):1731-1743.
[15]	Weinstock LB, Walters AS, Mullin GE, et al. Celiac disease is associated with restless legs syndrome[J]. Dig Dis Sci, 2010, 55(6):1667-1673.
[16]	Manchanda S, Davies CR, Picchietti D. Celiac disease as a possible cause for low serum ferritin in patients with restless legs syndrome[J]. Sleep Med, 2009, 10(7):763-765.
[17]	Uygur-Bayramicli O, Ozel AM. Celiac disease is associated with neurological syndromes[J]. Dig Dis Sci, 2011, 56(5):1587-1588.
[18]	Banno K, Delaive K, Walld R, et al. Restless legs syndrome in 218 patients: associated disorders[J]. Sleep Med, 2000, 1(3):221-229.
[19]	Salih AM, Gray RE, Mills KR, et al. A clinical, serological and neurophysiological study of restless legs syndrome in rheumatoid arthritis[J]. Br J Rheumatol, 1994, 33(1):60-63.
[20]	Yunus MB, Aldag JC. Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study[J]. BMJ, 1996, 312(7042):1339.
[21]	Bellini M, Gambaccini D, Stasi C, et al. Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy[J]. World J Gastroenterol, 2014, 20(27):8807-8820.
[22]	Tanaka Y, Kanazawa M, Fukudo S, et al. Biopsychosocial model of irritable bowel syndrome[J]. J Neurogastroenterol Motil, 2011, 17(2):131-139.
[23]	Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review[J]. JAMA, 2015, 313(9):949-958.
[24]	Padhy SK, Sahoo S, Mahajan S, et al. Irritable bowel syndrome: Is it "irritable brain" or "irritable bowel" ?[J]. J Neurosci Rural Pract, 2015, 6(4):568-577.
[25]	Pimentel M, Wallace D, Hallegua D, et al. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lac-tulose breath testing[J]. Ann Rheum Dis, 2004, 63(4):450-452.
[26]	Ringel Y, Sperber AD, Drossman DA. Irritable bowel syndrome[J]. Annu Rev Med, 2001, 52:319-338.
[27]	Weinstock LB, Walters AS. Restless legs syndrome is associated with irritable bowel syndrome and small intestinal bacterial over-growth[J]. Sleep Med, 2011, 12(6):610-613.
[28]	Borji R, Fereshtehnejad SM, Taba Taba Vakili S, et al. Association between irritable bowel syndrome and restless legs syndrome: a comparative study with control group[J]. J Neurogastroenterol Motil, 2012, 18:426-433.
[29]	Basu PP, Shah NJ, Krishnaswamy N, et al. Prevalence of rest-less legs syndrome in patients with irritable bowel syndrome[J]. World J Gastroenterol, 2011, 17(39):4404-4407.
[30]	Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology[J]. Lancet, 2007, 369:1627-1640.
[31]	Loftus EV Jr, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn’s disease in population-based patient cohorts from North America: a systematic review[J]. Aliment Pharmacol Ther, 2002, 16:51-60.
[32]	Shanahan F. Crohn's disease[J]. Lancet, 2002, 359(9300):62-69.
[33]	Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies[J]. Lancet, 2007, 369(9573):1641-1657.
[34]	Rothfuss KS, Stange EF, Herrlinger KR. Extraintestinal manifestations and complications in inflammatory bowel diseases[J]. World J Gastroenterol, 2006, 12(30):4819-4831.
[35]	Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn’s disease[J]. Aliment Pharmacol Ther, 2006, 24(11-12):1507-1523.
[36]	Gisbert JP, Gomollon F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease[J]. Am J Gastroenterol, 2008, 103(5):1299-1307.
[37]	Balfour Sartor R. Bacteria in Crohn’s disease: mechanisms of inflammation and therapeutic implications[J]. J Clin Gastroenterol, 2007, 41(suppl 1):S37-S43.
[38]	Biancone L, Vernia P, Agostini D, et al. Effect of rifaximin on intestinal bacterial overgrowth in Crohn’s disease as assessed by the H2-Glucose Breath Test[J]. Curr Med Res Opin, 2000, 16(1):14-20.
[39]	Shafran I, Johnson LK. An open-label evaluation of rifaximin in the treatment of active Crohn’s disease[J]. Curr Med Res Opin, 2005, 21(8):1165-1169.
[40]	Weinstock LB, Bosworth BP, Scherl EJ, et al. Crohn’s disease is associated with restless legs syndrome[J]. Inflamm Bowel Dis, 2010, 16(2):275-279.
[41]	Hoek PD, Smits MG, de Roos NM, et al. Increased prevalence of restless legs syndrome in patients with Crohn’s disease[J]. Eur J Gastroenterol Hepatol, 2015, 27(8):951-955.

Please choose a citation manager

Content to export